Brian Lucas Email

VP, Head Medicinal Chemistry . Fulcrum Therapeutics

Current Roles

Employees:
101
Revenue:
$22M
About
What if we could regulate genes, not just discover them What if we could treat disease at their genetic source What if we could integrate multiple disciplines to develop breakthrough medicines What if you could be a part of a passionate team committed to the patients we serve We can. We will. We Are. Join Us. We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. A fulcrum is defined as the point on which a lever rests, balances and pivots. Fulcrum Therapeutics is intervening in gene regulatory mechanisms to unlock the information contained in the human genome. The Fulcrum product engine is dedicated to bringing balance to the genetic on and off switches in disease. Our Approach The sequencing of the human genome has provided incredible insight into disease biology, yet the richness of biology comes from the dynamic on and off switches that control the genome gene regulation. The Fulcrum product engine is based on the breakthrough biology of gene regulation. It will bring to bear medicines for devastating diseases across multiple therapeutic areas by modulating or balancing the expression of the genes known to drive disease. By focusing on disease causative genes, we are taking a highly personalized approach to treating disease unlocking the druggable mechanisms that regulate disease genes to develop a new generation of disease-modifying therapies.
Fulcrum Therapeutics Address
26 Landsdowne Street
Cambridge, MA
United States

Past Companies

Fulcrum TherapeuticsVice President, Head of Medicinal Chemistry
Skyhawk TherapeuticsExecutive Director
Skyhawk TherapeuticsSenior Director

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.